Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Taking a regional hospital as an example, the investigators will discuss the changes in the community cumulative incidence rate(CIR) and the epidemic prevention effect of using Chinese medicine during the SARS-CoV-2 outbreak.
Main purpose:
Retrospective case study to explore the effect of traditional Chinese medicine on the prevention of SARS-CoV-2.
Secondary purpose:
If there are related side effects after taking Chinese medicine.
The large-scale coronavirus epidemic is a major global public health challenge in the 21st century. Since the 2003 Severe acute respiratory syndrome (SARS) epidemic spread globally and caused hundreds of deaths, the Middle East respiratory syndrome (Middle East respiratory syndrome, MERS) and coronavirus disease 2019(COVID-19) has caused a large-scale global spread and also caused a huge impact on the public health and medical system. In the country's current epidemic (Aug 1, 2021), more than 15,000 people have been diagnosed, and the number of deaths has exceeded 800. Among them, the Taipei epidemic is the most severe, and the Wanhua District of Taipei City is the hot zone. The investigators will discuss the changes in accumulation incidence rate(CIR) of the community and the epidemic prevention effect of using Chinese medicine during the SARS-CoV-2 outbreak.
This is a retrospective case study to explore the effect of traditional Chinese medicine on the prevention of SARS-CoV-2 and discuss if there are related side effects after taking Chinese medicine.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| JGF (Jing-Guan-Fang): Traditional Chinese Medicine Decoction | JGF group: 100ml JGF decoction per day at least 1 week |
| |
| NO JGF | NO JGF group: None use traditional Chinese medicine(JGF) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Jing-Guan-Fang(JGF) : Chinese herbal decoction | Drug | Use 100ml JGF decoction per day as a preventive measure for patients with COVID-19. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Investigation on the effect of using traditional Chinese medicine to prevent SARS-CoV-2 infection in two groups with cumulative incidence rate(CIR). | Compare the dangerous states within two groups with CIR. | 18 months |
Not provided
Not provided
Inclusion Criteria:
- From January 1, 2020 to July 31, 2021, Chinese medicine is used for patients with new coronary pneumonia epidemic prevention.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
The subjects of this study are patients who went to the Taipei City Hospital Linsen Chinese Medicine and Kunming Branch from January 1, 2020, to July 31, 2021. It is estimated that the medical records of 1,000 patients who use traditional Chinese medicine for new coronary pneumonia prevention and control will be collected as the experimental group, and they will be randomly matched. The medical records of 1,000 patients who have not used Chinese medicine as a control group for the prevention of new coronary pneumonia, a total of 2,000.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Taipei City Hospital | Taipei | 886 | Taiwan |
Not provided
Not provided
Not provided
Not provided
|
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D014777 | Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided